Latest stories on INCY
Incyte Corp. stock underperforms Friday when compared to competitors
MarketWatch42 · neutralgeneral
Profitable Biotech Incyte Stock Forms Handle Amid Strong Institutional Accumulation
Investors.com63 · neutralgeneral
Profitable Biotech Incyte Forms Handle As Institutional Buyers Load Up On Stock
Investors.com63 · neutralgeneral
Incyte Corp. stock outperforms competitors despite losses on the day
MarketWatch58 · neutralgeneral
Incyte Corporation (INCY) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript
Seeking Alpha55 · neutralgeneral
Incyte Corp. stock outperforms competitors on strong trading day
MarketWatch63 · neutralgeneral
Incyte Corporation (INCY) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Seeking Alpha55 · neutralgeneral
Incyte Corp. stock outperforms competitors despite losses on the day
MarketWatch58 · neutralgeneral
Incyte: Solid Strategies For Continued Growth, But A Possible Pullback Looms
Seeking Alpha58 · neutralgeneral
Incyte Corporation: Why Jakafi Is No Longer The Real Story Here
Seeking Alpha67 · bullishanalyst
Incyte to Present at Upcoming Investor Conferences
StockTitan56 · neutralgeneral
BMO reiterates Incyte stock rating on CMS pricing agreement
Investing.com Analyst Ratings56 · neutralanalyst
INCYTE CORP (INCY) files 8-K
SEC 8-K50 · neutralgeneral
Josh Brown Says ‘Take a Break From AI CapEx World,’ Highlights His 2 Top Healthcare Stock Picks
Yahoo Finance56 · neutralanalyst
Incyte initiated with a Buy at Canaccord
The Fly61 · neutralanalyst
Incyte Corp. stock underperforms Wednesday when compared to competitors despite daily gains
MarketWatch48 · neutralgeneral
Incyte ‘734 update likely to be ‘very competitive,’ says RBC Capital
The Fly64 · neutralanalyst
Incyte Stock: Is Wall Street Bullish or Bearish?
Yahoo Top56 · neutralanalyst
Incyte Stock: Is Wall Street Bullish or Bearish?
Barchart56 · neutralanalyst
Incyte price target raised to $130 from $110 at Piper Sandler
The Fly61 · neutralanalyst
Incyte Corporation (INCY) has the Bigger Revenue Base, but Could Halozyme Therapeutics, Inc. (HALO) have the Better Economics?
Yahoo Finance63 · neutralproduct/pr
Incyte Sales Growth Drives Share Price Gains
Yahoo Top68 · bullishearnings
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral